Karoo Health Raises $16.2 Million to Advance AI Cardiovascular Platform
Karoo Health has raised $16.2 million in a Series A round co-led by 7wire Ventures and Allumia Ventures, according to a press release. Other participants include First Trust Capital Partners, SpringRock Ventures, and Hyde Park Angels.
The Albuquerque-based company is developing an AI cardiovascular platform designed to connect payers, providers, and patients through unified data and workflow systems that support early risk detection and care coordination. The funds will be used to further develop predictive models, signal detection capabilities, and clinical infrastructure, as well as to expand engineering and clinical teams.
As part of the financing, Lee Shapiro from 7wire Ventures and Jeff Stolte from Allumia Ventures will join Karoo Health’s board of directors. The company currently supports more than 600 cardiology providers across 11 U.S. states and works with several national and regional health plans. Analyses of existing programs have shown a reduction in emergency department visits and inpatient admissions by more than 40 percent and an over 10 percent reduction in overall care costs.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Nov 2 BRIGHT Receives €3.7 Million for AI Cancer Microscope Nov 2 Anthropic Reports $17 Billion Quarterly Revenue and $895 Billion in Compute Commitments Nov 2 Omen AI Acquires Aquatic Labs for $16 Million Nov 2 Marvell Agrees to Buy Lumentum in $115 Billion Stock Deal Nov 2 Creandum closes $750 million eighth fund as it rebuilds around AIMore from Life Sciences
Nov 2 BRIGHT Receives €3.7 Million for AI Cancer Microscope Nov 2 Healthcare Triangle Identifies Up to $45 Million Indonesia Pipeline Nov 2 EClinCloud Analysis Reviews 1,715 FDA Inspection Citations Nov 2 DarioHealth to Report Third Quarter Results on November 12 Nov 2 Signia brings MaX AI hearing aid to US government health programsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Healthleap Raises $38 Million for Hospital Risk Screening AI
Midstream Health Raises $20M to Recover Hospital Payments
BioStack Raises $9.5 Million for Medical AI Data Network
Atlas Bio raises $12.5 million for virtual drug trials
Azra AI Acquires Blackford Analysis
Daily AI Brief: the AI news that matters, in your inbox.